Clincosm LogoSign in Get a demo

Renal Cell Carcinoma

Showing 76 - 100 of 513
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Bempegaldesleukin, Axitinib)

Active, not recruiting
  • Renal Cell Carcinoma
  • Nivolumab
  • +2 more
  • Springdale, Arkansas
  • +33 more
Nov 22, 2022

Quantifying Systemic Immunosuppression to Personalize Cancer

Recruiting
  • Melanoma
  • +6 more
  • MDSC quantification
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Nov 11, 2022

Renal Cell Carcinoma, Hepatocellular Carcinoma Trial in Tucson (Social Support Network Intervention, Control (Patient Navigation

Withdrawn
  • Renal Cell Carcinoma
  • Hepatocellular Carcinoma
  • Social Support Network Intervention
  • Control (Patient Navigation Service)
  • Tucson, Arizona
    University of Arizona
Nov 15, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Renal Cell Carcinoma, Circulating Tumor Cell Trial in Lisboa (No-touch laparoscopic radical nephrectomy, Conventional

Completed
  • Renal Cell Carcinoma
  • Circulating Tumor Cell
  • No-touch laparoscopic radical nephrectomy
  • +2 more
  • Lisboa, Lisbon, Portugal
    Urology Department - Hospital de Santa Maria
Nov 10, 2022

Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • New Haven, Connecticut
  • +12 more
Nov 3, 2022

Hepatocellular Carcinoma, Metastatic Castration Resistant Prostate Cancer, Renal Cell Carcinoma Trial in United States (Part 1

Active, not recruiting
  • Hepatocellular Carcinoma
  • +11 more
  • Part 1 TPST-1120
  • +3 more
  • San Francisco, California
  • +10 more
Nov 1, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Renal Cell Carcinoma Trial in Leeds (Low dose abdominal computed tomography scan)

Active, not recruiting
  • Renal Cell Carcinoma
  • Low dose abdominal computed tomography scan
  • Leeds, Yorkshire, United Kingdom
    Leads Teaching Hospitals Trust
Nov 1, 2022

Renal Cell Carcinoma Trial in United States (Nivolumab, Ipilimumab)

Completed
Has Results
  • Renal Cell Carcinoma
  • Muscle Shoals, Alabama
  • +60 more
Oct 6, 2022

Breast Cancer, Ovarian Cancer, Non Small Cell Lung Cancer Trial in San Francisco, Denver, San Antonio (P-MUC1C-ALLO1 CAR-T

Recruiting
  • Breast Cancer
  • +8 more
  • San Francisco, California
  • +4 more
Oct 26, 2022

Renal Cell Carcinoma Trial in Australia, Korea, Republic of, United States (Pexastimogene Devacirepvec (Pexa-Vec), Cemiplimab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Pexastimogene Devacirepvec (Pexa-Vec)
  • Cemiplimab
  • Irvine, California
  • +17 more
Oct 26, 2022

Renal Cell Carcinoma Trial in Chapel Hill (Survey Questionnaire)

Recruiting
  • Renal Cell Carcinoma
  • Survey Questionnaire
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 19, 2022

Non Small Cell Lung Cancer, Urothelial Cancer, Renal Cell Carcinoma Trial in Worldwide (INCB086550)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Burgas, Bulgaria
  • +19 more
Oct 20, 2022

Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

Recruiting
  • Adenocarcinoma
  • +75 more
  • Biomarker Testing (L)
  • +2 more
  • Idaho Falls, Idaho
  • +1 more
Oct 18, 2022

Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

Temporarily not available
  • Epithelioid Sarcoma (Ex-US Only)
  • +19 more
  • (no location specified)
Oct 17, 2022

Renal Cell Carcinoma Trial in Switzerland (nivolumab, ipilimumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Aarau, Switzerland
  • +13 more
Oct 17, 2022

Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)

Active, not recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
  • +1 more
Oct 11, 2022

Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Non-small-cell Lung Cancer
  • +5 more
  • PF-07209960
  • Duarte, California
  • +11 more
Oct 10, 2022

Renal Cell Carcinoma, Kidney Tumor, Renal Cancer Trial in New York (Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250))

Completed
Has Results
  • Renal Cell Carcinoma
  • +3 more
  • Yttrium-90 conjugated chimeric G250 (^90Y-DOTA-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)

Recruiting
  • Solid Tumor
  • +11 more
  • TRK-950
  • +14 more
  • Scottsdale, Arizona
  • +13 more
Oct 2, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Axitinib Dose Reduction and Interruption for Adverse Event

Completed
  • Renal Cell Carcinoma
  • New York, New York
    Pfizer
Sep 15, 2022

Soft Tissue Sarcoma, Renal Cell Carcinoma, Uterine Carcinosarcoma Trial in United States (HFB301001)

Recruiting
  • Soft Tissue Sarcoma
  • +4 more
  • Scottsdale, Arizona
  • +9 more
Sep 13, 2022

Frequency, Clinical Phenotype and Genetic Analysis of Heritable

Not yet recruiting
  • Renal Tumor Histology
  • +13 more
  • Gene test
  • Shanghai, Shanghai, China
    Ethics Committee of Shanghai Renji Hospital
Sep 6, 2022